Epidemiology of atherosclerotic arterial disease in the lower limbs

European Journal of Vascular Surgery

Volumn 2, Issue 5, 1988, Pages 283-291

  Fowkes, F G R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; LIPID;

ADULT; AGED; BLOOD PRESSURE; HUMAN; PERIPHERAL VASCULAR DISEASE; SHORT SURVEY; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; EUROPE; FEMALE; HUMAN; LEG; MALE; MIDDLE AGE; UNITED STATES;

EID: 0024161171     PISSN: 0950821X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-821X(88)80002-1     Document Type: Review

References (86)

1. Autopsy Studies in Atherosclerosis: I. Distribution and Severity of Atherosclerosis in Patients Dying without Morphologic Evidence of Atherosclerotic Catastrophe
2. Atherosclerosis in a defined population
3. Occlusion of peripheral arteries: a study of 6,400 working subjects
4. A cardiovascular survey of British postal workers
5. Characteristics of smokers and nonsmokers in Tecumseh, Michigan
6. A cardiovascular survey of American East Coast telephone workers
7. Ischaemic heart disease in middle aged men
8. Depistage par questionnaire de l'insuffisance coronarienne et de la claudication intermittente
9. Venous occlusion plethysmography in 55 year old men: a population study in Malmo, Sweden
10. Physical fitness and coronary heart disease in male residents in Copenhagen aged 40–59
11. Cardiorespiratory disease and diabetes among middle aged male civil servants
12. Prevalence of ischaemic heart disease, arterial hypertension and intermittent claudication, and distribution of risk factors among middle aged men in Moscow and Berlin
13. Smoking, carbon monoxide and atherosclerotic diseases
14. Intermittent claudication: prevalence and risk factors
15. Intermittent claudication—epidemiology and natural history
16. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60 year old men and women
17. Prevalence of intermittent claudication and its effect on mortality
18. The prevalence of peripheral arterial disease in a defined population
19. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys
20. Self administration of a questionnaire on chest pain and intermittent claudication
21. Intermittent claudication and peripheral pulses in older people
22. Intermittent claudication: incidence in the Framingham Study
23. Update on some epidemiological features of intermittent claudication: The Framingham Study
24. Risk profile and occlusive peripheral artery disease (OPAD)
25. The Measurement of Atherosclerotic Peripheral Arterial Disease in Epidemiological Surveys
26. Life expectancy following aortofemoral arterial grafting
27. Autogenous venous grafts ten years later
28. Autogenous vein grafting in femoropopliteal atherosclerosis: the limits of its effectiveness
29. Aortoiliac occlusive disease: factors influencing survival and function following reconstructive operation over a twenty five year period
30. Fatal myocardial infarction following lower extremity revascularization—two hundred and seventy three patients followed six to eleven post operative years
31. Coronary artery disease in peripheral vascular patients—a classification of 1000 coronary angiograms and results of surgical management
32. Cardiovascular disease and occlusive peripheral artery disease (OPAD)
33. The natural history of arteriosclerosis obliterans
34. Cigarette smoking and peripheral atherosclerotic occlusive disease
35. Hyperlipoproteinaemia in peripheral arterial disease in the north of England
36. Diet lipids and lipoproteins in patients with peripheral vascular disease
37. THE SMOKING HABITS OF MEN WITH INTERMITTENT CLAUDICATION
38. The Framingham study
39. The Basic longitudinal study: report on the relation of initial glucose level to baseline ECG abnormalities, peripheral artery disease, and subsequent mortality
40. Predisposition to atherosclerosis in the head, heart and legs
41. Arteriosclerosis obliterans: review of 520 cases with special reference to pathogenic and prognostic factors
42. Serum lipids and lipoproteins in peripheral vascular disease
43. Metabolic and cardiovascular abnormalities in patients with peripheral arterial disease
44. “Risk factors” and manifestations of arteriosclerosis in patients with intermittent claudication compared to normal persons
45. Diabetes, hyperglyaemia and arterial disease
46. Morbidity and mortality in diabetics in the Framingham population
47. Abnormalities in glucose tolerance, lipid and lipoprotein levels in patients with atherosclerotic peripheral arterial disease
48. Hyperlipidaemia in peripheral atherosclerotic arterial disease
49. Smoking and arterial reconstruction
50. Lipoproteins, fibrinolytic activity and fibrinogen in patients with occlusive vascular disease and in healthy subjects with a family history of heart attacks
51. Serum lipoproteins and apolipoproteins Al and All in male patients with peripheral arterial insufficiency
52. Serum lipids and high density lipoproteins in peripheral vascular disease
53. Humoral changes in arteriosclerosis. Investigations on lipids, fatty acids, ketone bodies, pyruvic acid, lactic acid, and glucose in the blood.
54. Clinical, haemodynamic, rheological and biochemical findings in 126 patients with intermittent claudication
55. Hyperlipoproteinamien bei peripheren arteriellen Verschlusskrankheiten
56. A lipid and lipoprotein study of patients with peripheral arterial disease using micro-nephelometry
57. Plasma high density lipoproteins in coronary, cerebral and peripheral vascular diseases
58. High density lipoprotein cholesterol levels in peripheral vascular disease and in women on oral contraception
59. Retrospective evaluation of risk factors for peripheral, atherosclerosis by stepwise discriminant analysis
60. Increased apoprotein B in very low density lipoproteins of patients with peripheral vascular disease
61. Modified composition of very low density lipoproteins in peripheral vascular disease: evidence for low cholesterol ester but normal apoliprotein B content of small VLDL
62. Filter coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy
63. Fibrinogen, factor VIII related antigen, anti-thrombin III and alpha 2-antiplasmin in peripheral arterial disease
64. Studies on haematocrit in peripheral arterial disease
65. Elevation of blood viscosity, aggregation of red cells, haematocrit values and fibrinogen levels in cigarette smokers
66. Factors influencing prognosis in the surgery of peripheral arterial disease
67. The importance of plasma lipids, glucose, insulin and fibrinogen in femoropopliteal surgery
68. Elevated haematocrit in patients with intermittent claudication with special regard to men below the age of 60
69. The influence of haemaglobin and platelet levels on the results of arterial surgery
70. Gout and cardiovascular disease
71. Blood viscosity in patients with peripheral vascular disease in the areas of low shear rates
72. Blood rheology in arterial disease
73. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease
74. Occlusive peripheral artery disease (OPAD)
75. PROGNOSIS IN ARTERIOSCLEROTIC PERIPHERAL VASCULAR DISEASE
76. The Fate of the Claudicator
77. Natural History of Arteriosclerosis of the Lower Extremities: Hunterian Lecture delivered at the Royal College of Surgeons of England on 22nd April 1960.
78. Chronic Atherosclerotic Occlusion of the Femoral Artery
79. The prognosis of intermittent claudication
80. Atherosclerosis of arteries of lower limbs
81. Some factors influencing the spontaneous course of arterial vascular insufficiency
82. Intermittent claudication: factors determining outcome
83. Mortality and morbidity in patients with intermittent claudication as defined by venous occlusion plethysmography
84. Intermittent claudication
85. Fate in intermittent claudication: outcome and risk factors